Secondary Hyperparathyroidism Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Drug Class (Vitamin D Analogs, Calcimimetics, Phosphate Binders, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Region and Competition

Published	Pages	Publisher	Report code
Feb 2024	186	TechSci Research	ASDR-657591

Published: Feb 2024 - Pages : 186 - Publisher : TechSci Research - Report code : ASDR-657591

1. Opko Health
Inc
2. Amgen Inc.
3. Tairui Biotechnology Co. Ltd.
4. Sanofi SA
5. Validus Pharmaceuticals LLC
6. AbbVie Inc.
7. Ono Pharmaceutical Co. Ltd
8. Kyowa Kirin Co. Ltd.
9. Teva Pharmaceutical Industries Ltd
10. Pharmanovia

Secondary Hyperparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Secondary Hyperparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Upda...

Published: March, 2022 | Report code: ASDR-599085